Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Externally-applied medicine for treating dermatopathy caused by pathogenic fungi and preparation method thereof

A technology for topical medicines and skin diseases, which can be applied to skin diseases, medical preparations containing active ingredients, antifungal agents, etc., and can solve problems such as lack of therapeutic drugs

Inactive Publication Date: 2014-10-29
李太玲
View PDF4 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

There are many Chinese and Western medicines for the treatment of skin diseases, but there is still a lack of safe and effective therapeutic drugs for skin diseases caused by pathogenic fungi.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

specific Embodiment 1

[0026] Take 10 grams of clotrimazole cream, 15 grams of fluocinolone ointment, 0.6 grams of metronidazole (3 metronidazole tablets each containing 0.2 grams of metronidazole), 1.5 grams of chloramphenicol (each tablet contains chloramphenicol 0.25 grams of chloramphenicol tablets 6), borneol 1 gram, rivanol powder 0.2 grams, prednisone 0.05 grams (10 prednisone tablets each containing 5 mg of prednisone). Crush 3 metronidazole tablets, 6 chloramphenicol tablets, and 10 prednisone tablets into fine powder, mix them with borneol and rivanol powder, add 10 grams of clotrimazole cream and 15 grams of fluocinolone ointment, According to the conventional process of ointment in this area, the external ointment for treating skin diseases of the present invention is made.

specific Embodiment 2

[0027] Take 20 grams of clotrimazole cream, 25 grams of fluocinolone ointment, 1.0 grams of metronidazole (5 metronidazole tablets each containing 0.2 grams of metronidazole), 2.0 grams of chloramphenicol (each tablet contains chloramphenicol 0.25 grams of chloramphenicol tablets 8), borneol 5 grams, rivanol powder 0.8 grams, prednisone 0.15 grams (30 prednisone tablets containing 5 mg of prednisone per tablet). Crush 5 metronidazole tablets, 8 chloramphenicol tablets, and 30 prednisone tablets into fine powder and mix them with borneol and rivanol powder evenly, add 20 grams of clotrimazole cream and 25 grams of fluocinolone ointment, The external liniment for treating skin diseases of the present invention is made according to the conventional process of the external liniment in the art.

specific Embodiment 3

[0028] Take 15 grams of clotrimazole cream, 20 grams of fluocinolone ointment, 0.8 grams of metronidazole (4 metronidazole tablets each containing 0.2 grams of metronidazole), 1.75 grams of chloramphenicol (each tablet contains chloramphenicol 0.25 grams of chloramphenicol tablets 7), borneol 3 grams, rivanol powder 0.5 grams, prednisone 0.1 grams (20 prednisone tablets each containing 5 mg of prednisone). Crush 4 metronidazole tablets, 7 chloramphenicol tablets, and 20 prednisone tablets into fine powder and mix them with borneol and rivanol powder evenly, add 15 grams of clotrimazole cream and 20 grams of fluocinolone ointment, The external spray for treating skin diseases of the present invention is made according to the conventional process of the external spray in the art.

[0029] A large number of clinical medical practices have proved that the medicine for external use for treating skin diseases caused by pathogenic fungi belongs to external preparations, has little to...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses an externally-applied medicine for treating dermatopathy caused by pathogenic fungi, and is characterized in that the externally-applied medicine is prepared from the following medicines in parts by weight: 10-20 parts of a clotrimazole cream, 15-25 parts of a fluocinolone acetonide ointment, 0.6-1.0 part of metronidazole, 1.5-2.0 parts of chloramphenicol, 1-5 parts of borneol, 0.2-0.8 part of a rivanol powder, and 0.05-0.15 part of prednisone. Clinic experiments prove that the externally-applied medicine can safely and effectively treat the dermatopathy caused by the pathogenic fungi.

Description

technical field [0001] The invention relates to an externally-used medicine formula, in particular to an externally-used medicine for treating skin diseases caused by pathogenic fungi and a preparation method thereof. Background technique [0002] Common classification and symptoms of skin diseases: 1. Fungal diseases: common tinea pedis, tinea corporis, and tinea unguium (onychomycosis); 2. Bacterial skin diseases: common erysipelas and leprosy; 3. Viral skin diseases: The common ones are chickenpox, flat warts and herpes; 4. Skin diseases caused by arthropods: such as scabies; 5. Sexually transmitted diseases: such as syphilis, gonorrhea and genital warts; 8. Neurological dysfunction skin diseases: common skin diseases caused by pruritus, neurodermatitis and parasites; 9. Erythematous papular scaly skin diseases: common psoriasis, psoriasis , pityriasis simplex and pityriasis rosea; 10. Connective tissue diseases: common lupus erythematosus, scleroderma and dermatomyositi...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K31/58A61P31/10A61P17/00A61K31/4174A61K31/4164A61K31/165A61K31/045A61K31/473A61K31/573
Inventor 李太玲刘立红王冬青滕丽丽
Owner 李太玲
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products